Healthcare -
Biotechnology - NASDAQ - US
$ 10.39
-1.14 %
$ 1.06 B
Market Cap
-1.91
P/E
NTLA - SHORT-TERM DEBT
Short-term Debt NTLA - Intellia Therapeutics, Inc.
32.4 M
LAST VALUE
33.31%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR